BlackRock Fund Advisors’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Hold
0
– – – 4010
2016
Q3
– Hold
0
– – – 4040
2016
Q2
– Hold
0
– – – 4093
2016
Q1
– Hold
0
– – – 3594
2015
Q4
– Hold
0
– – – 3553
2015
Q3
– Hold
0
– – – 3438
2015
Q2
– Sell
-2
Closed -$4.36M – 3310
2015
Q1
$3.69M Hold
2
– – ﹤0.01% 2979
2014
Q4
$5.33M Buy
2
+1
+100% +$3.29M ﹤0.01% 2839
2014
Q3
$5.43M Hold
1
– – ﹤0.01% 2700
2014
Q2
$7.2M Buy
+1
New +$4.7M ﹤0.01% 2618
2014
Q1
– Hold
0
– – – 3206
2013
Q4
– Hold
0
– – – 3236
2013
Q3
– Hold
0
– – – 3215
2013
Q2
– Hold
0
– – – 3305

Other funds holding PALI

BlackRock Fund Advisors's PALI Position: Q4 2016 in Review

BlackRock Fund Advisors held its Palisade Bio (PALI) position steady in Q4 2016 at 0 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4010.

BlackRock Fund Advisors first reported a position in PALI in Q2 2014 and has held it in 4 quarters since. The position peaked at $7.2M in Q2 2014. 3 funds tracked by Wall St. Rank hold PALI as of Q4 2016.

  • BlackRock Fund Advisors held 0 shares of Palisade Bio worth $7K as of Q4 2016.
  • BlackRock Fund Advisors left its Palisade Bio share count unchanged in Q4 2016.
  • Palisade Bio made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #4010 holding.
  • BlackRock Fund Advisors first reported a position in Palisade Bio in Q2 2014 and has held it in 4 quarters since.
  • BlackRock Fund Advisors's Palisade Bio position peaked at $7.2M in Q2 2014.
  • 3 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.